Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Putz

Showing results (61-70 of 75) with videos related to

Pageof 8
Sort By:
Journal of Animal Science|January 13, 2023
Plasma protein levels of young healthy pigs as indicators of disease resilienceYulu Chen, Steven Lonergan, Kyu-Sang Lim, et al.
BMC Genomics|July 14, 2021
Investigating the genetic architecture of disease resilience in pigs by genome-wide association studies of complete blood count traits collected from a natural disease challenge modelXuechun Bai, Tianfu Yang, Austin M Putz, et al.
The EMBO Journal|December 25, 2007
The structure of the C-terminal actin-binding domain of talinAlexandre R Gingras, Neil Bate, Benjamin T Goult, et al.
The Journal of Clinical Investigation|July 1, 2024
NK cell heparanase controls tumor invasion and immune surveillanceEva M Putz, Alyce J Mayfosh, Kevin Kos, et al.
The Journal of Clinical Investigation|June 6, 2017
NK cell heparanase controls tumor invasion and immune surveillanceEva M Putz, Alyce J Mayfosh, Kevin Kos, et al.
Leukemia|November 23, 2013
PAK-dependent STAT5 serine phosphorylation is required for BCR-ABL-induced leukemogenesisA Berger, A Hoelbl-Kovacic, J Bourgeais, et al.
Oncoimmunology|November 22, 2012
Conditional IFNAR1 ablation reveals distinct requirements of Type I IFN signaling for NK cell maturation and tumor surveillanceTatsuaki Mizutani, Nina Neugebauer, Eva M Putz, et al.
Nature Communications|August 22, 2020
Engineering AvidCARs for combinatorial antigen recognition and reversible control of CAR functionBenjamin Salzer, Christina M Schueller, Charlotte U Zajc, et al.
Cancer Discovery|February 14, 2016
STAT5 Is a Key Regulator in NK Cells and Acts as a Molecular Switch from Tumor Surveillance to Tumor PromotionDagmar Gotthardt, Eva M Putz, Eva Grundschober, et al.
Blood|September 1, 2011
The cooperating mutation or "second hit" determines the immunologic visibility toward MYC-induced murine lymphomasChristian Schuster, Angelika Berger, Maria A Hoelzl, et al.
Pageof 8

Showing results (61-70 of 75) with videos related to

Sort By:
Pageof 8
Journal of Animal Science|January 13, 2023
Plasma protein levels of young healthy pigs as indicators of disease resilienceYulu Chen, Steven Lonergan, Kyu-Sang Lim, et al.
BMC Genomics|July 14, 2021
Investigating the genetic architecture of disease resilience in pigs by genome-wide association studies of complete blood count traits collected from a natural disease challenge modelXuechun Bai, Tianfu Yang, Austin M Putz, et al.
The EMBO Journal|December 25, 2007
The structure of the C-terminal actin-binding domain of talinAlexandre R Gingras, Neil Bate, Benjamin T Goult, et al.
The Journal of Clinical Investigation|July 1, 2024
NK cell heparanase controls tumor invasion and immune surveillanceEva M Putz, Alyce J Mayfosh, Kevin Kos, et al.
The Journal of Clinical Investigation|June 6, 2017
NK cell heparanase controls tumor invasion and immune surveillanceEva M Putz, Alyce J Mayfosh, Kevin Kos, et al.
Leukemia|November 23, 2013
PAK-dependent STAT5 serine phosphorylation is required for BCR-ABL-induced leukemogenesisA Berger, A Hoelbl-Kovacic, J Bourgeais, et al.
Oncoimmunology|November 22, 2012
Conditional IFNAR1 ablation reveals distinct requirements of Type I IFN signaling for NK cell maturation and tumor surveillanceTatsuaki Mizutani, Nina Neugebauer, Eva M Putz, et al.
Nature Communications|August 22, 2020
Engineering AvidCARs for combinatorial antigen recognition and reversible control of CAR functionBenjamin Salzer, Christina M Schueller, Charlotte U Zajc, et al.
Cancer Discovery|February 14, 2016
STAT5 Is a Key Regulator in NK Cells and Acts as a Molecular Switch from Tumor Surveillance to Tumor PromotionDagmar Gotthardt, Eva M Putz, Eva Grundschober, et al.
Blood|September 1, 2011
The cooperating mutation or "second hit" determines the immunologic visibility toward MYC-induced murine lymphomasChristian Schuster, Angelika Berger, Maria A Hoelzl, et al.
Pageof 8